BOSTON, MA—Andrew (A.J.) Tibbetts, a shareholder at global law firm Greenberg Traurig, LLP, presented at the Massachusetts Biotechnology Council (MassBio) forum Sept. 11.
Tibbetts presented “AI and Machine Learning: Parsing Hype from Real Successes in the Life Sciences,” discussing how AI and machine learning may have the potential to revolutionize drug discovery and clinical trials, as well as a lack of clinical data and its impact in life sciences. Additionally, he broke down what to expect from these technologies in the coming years based on real-world successes.
Tibbetts, an Intellectual Property & Technology shareholder in the firm’s Boston office, leverages prior experience as a software engineer to provide practical intellectual property strategy counseling on matters related to software-implemented tech across a range of industries, from networking, fintech, and natural language processing through to life sciences, artificial intelligence, medical records, and medical devices.
The post Andrew Tibbetts Presents at MassBio Forum on AI and Machine Learning appeared first on Attorney at Law Magazine.